Cite

HARVARD Citation

    Caroen, S. et al. (2020). Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix. Expert opinion on drug delivery. pp. 741-742. [Online]. 
  
Back to record